Financing · Healthtech
Weican Medical secures financing for implantable drug-delivery devices
Dongnan Fund and Nuoyu Capital invested in the Nanjing medical-device developer.
Weican Medical has secured financing from Dongnan Fund and existing investor Nuoyu Capital, according to a March 1 announcement from Nanjing. The amount and round label were not disclosed.
The company develops minimally invasive implanted ports for drug delivery. Its team combines clinical practice, mechanical design, materials science and medical-device registration expertise.
The financing supports further technology development, production capabilities and commercialization of its implantable devices.
Use of funds
Develop implantable drug-delivery devices and expand production
Funding history
Financing · This roundUndisclosed